← back to search

David M. Smadja

Vall d'Hebron Institut de Recerca · FR
Area of research
Molecular Biology · Internal Medicine
Research interest
Research interests include Angiogenesis and VEGF in Cancer, Venous Thromboembolism Diagnosis and Management, COVID-19 Clinical Research Studies, and Pulmonary Hypertension Research and Treatments.
h-index
50
citations
16,139
works
399
NIH funding
primary concept
Medicine
email

Recent publications

Thrombin cleaves membrane-bound endoglin potentially contributing to the heterogeneity of circulating endoglin in preeclampsia
Communications Biology 2025cited by 7position: middledoi
Molecular determinants of thrombosis recurrence risk across venous thromboembolism subtypes
Blood 2025cited by 7position: middledoi
Elevated plasma complement factor H related 5 protein is associated with venous thromboembolism
Nature Communications 2023cited by 36position: middledoi
Author Correction: Elevated plasma complement factor H related 5 protein is associated with venous thromboembolism
Nature Communications 2023cited by 3position: middledoi
Cross-Ancestry Investigation of Venous Thromboembolism Genomic Predictors
Circulation 2022cited by 103position: middledoi
Cross-Ancestry Investigation of Venous Thromboembolism Genomic Predictors
medRxiv 2022cited by 4position: middledoi
COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects
Angiogenesis 2021cited by 202position: firstdoi
Autoantibodies against type I IFNs in patients with life-threatening COVID-19
Science 2020cited by 2,832position: middledoi
Human Aortic Valve Interstitial Cells Display Proangiogenic Properties During Calcific Aortic Valve Disease
Arteriosclerosis Thrombosis and Vascular Biology 2020cited by 32position: lastdoi
Recommandations de bonne pratique pour la prise en charge de la maladie veineuse thromboembolique chez l’adulte. Version courte
Revue des Maladies Respiratoires 2019cited by 131position: middledoi
PDGFB, a new candidate plasma biomarker for venous thromboembolism: results from the VEREMA affinity proteomics study
Blood 2016cited by 58position: middledoi
Meta-analysis of 65,734 Individuals Identifies TSPAN15 and SLC44A2 as Two Susceptibility Loci for Venous Thromboembolism
The American Journal of Human Genetics 2015cited by 271position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 2 papers (2020–2021)Nicolas Gendron · Université Claude Bernard Lyon 12 papers (2020–2021) · 2 papers (2020–2025) · 2 papers (2020–2025)Elisabeth J. M. Huijbers · Science for Life Laboratory1 papers (2021–2021)Angela Silveira · Karolinska Institutet1 papers (2016–2016)Mun-Gwan Hong · Science for Life Laboratory1 papers (2016–2016)Julie Helms · Hôpital Saint-Louis1 papers (2021–2021) · 1 papers (2016–2016) · 1 papers (2025–2025) · 1 papers (2020–2020)Carmelo Bernabéu · National Research Council1 papers (2025–2025)Jochen M. Schwenk · Science for Life Laboratory1 papers (2016–2016)Laura Sánchez‐Rivera · Science for Life Laboratory1 papers (2016–2016)Claudia Fredolini · Science for Life Laboratory1 papers (2016–2016) · 1 papers (2025–2025)Patrycja Nowak‐Sliwinska · University of Geneva1 papers (2021–2021)Ivan Bièche · Institut Curie1 papers (2020–2020)Thibault Pamart · Inserm1 papers (2020–2020)Éric Van Belle · Inserm1 papers (2020–2020)